Inveready Evergreen S.C.R. S.A.

This profile gathers the share dealings of Inveready Evergreen S.C.R. S.A. in Atrys Health, S.A. In total, 6 filings cover trades dated from 17 April 2023 to 18 November 2025.

In open-market terms, that means 4 purchases worth €524k on one side and 1 sale worth €2.1M on the other. On balance, insiders were net sellers of €1.6M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2025 alone, the filings show 1 purchase and 1 sale.

The median purchase comes to €97k. Scaled by market value, the purchases weigh a median 0.048% of market cap (sample: 4 purchases). Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 20 November 2025 with an open-market purchase (€306k) in Atrys Health, S.A. Between a trade and the moment it shows up on CNMV, the median delay is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from CNMV. Past trades are no guide to future returns.